医薬品用脂質ベース賦形剤の世界市場レポート 2025年

医薬品用脂質ベース賦形剤の市場規模は、今後数年間で力強い成長が見込まれます。2029年には22億2,000万米ドルまで成長し、CAGRは5.5%に達します。予測期間中の成長は、先進ドラッグデリバリーシステムに対する需要の増加、mRNAや遺伝子治療の採用拡大、難水溶性薬剤のパイプライン拡大、個別化医療への重点化、支持的な規制枠組み、バイオ医薬品製造インフラへの戦略的投資などに起因すると考えられます。この間の主な動向としては、脂質ナノ粒子デリバリーシステムの革新、mRNAや遺伝子治療の幅広い採用、難水溶性薬物の溶解性ソリューションの強化、生体適合性と持続可能性に優れた脂質ソースの拡大、製造スケーラビリティの向上、経口剤や注射剤への利用の拡大などが挙げられます。

遺伝子治療の成長は、医薬品用脂質ベース賦形剤市場の拡大を加速すると予想されます。遺伝子治療には、病気の治療や予防のために人の遺伝子を修正したり操作したりすることが含まれます。遺伝子治療市場の拡大には、安全で効率的な、標的を絞った遺伝子物質の細胞内への輸送を確実にする送達システムの進歩が大きく寄与しています。医薬品用脂質ベース賦形剤は、効率的な送達システムを可能にし、安定性を提供し、遺伝物質の標的輸送を確実にすることにより、遺伝子治療を強化する上で重要な役割を果たしています。これらの賦形剤は、核酸を保護し、細胞への取り込みを促進することにより治療成績を向上させ、最新の治療の有効性を高めています。例えば、2024年12月、米国の非営利団体である米国遺伝子・細胞治療学会（ASGCT）は、米国食品医薬品局（FDA）が2023年に6つの遺伝子治療製品を承認し、2022年の5つから増加したと報告しました。このような遺伝子治療の動向が医薬品用脂質ベース賦形剤の需要を牽引しています。

医薬品用脂質ベース賦形剤市場の主要企業は、技術革新の促進、製剤能力の強化、ドラッグデリバリー研究の支援のために戦略的投資を行っています。フランスを拠点とする化学品製造会社Gattefosse SASは、2024年11月にムンバイに最先端のテクニカルセンター・オブ・エクセレンスを開設しました。この施設は、特にバイオアベイラビリティ、徐放性、局所製剤などの賦形剤の革新のために、専門的な研究室とオーダーメイドのサポートを提供し、成長するインドの医薬品市場をサポートすることを目的としています。また、アジア太平洋地域におけるガットフォッセの地位も強化されます。新施設は、共同研究を奨励し、イノベーションを促進するよう設計されており、医薬品およびパーソナルケア用途の研究に生産的な環境を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品用脂質ベース賦形剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医薬品用脂質ベース賦形剤市場：成長率分析
• 世界の医薬品用脂質ベース賦形剤市場の実績：規模と成長, 2019-2024
• 世界の医薬品用脂質ベース賦形剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界の医薬品用脂質ベース賦形剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品用脂質ベース賦形剤市場：添加剤タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オイル
• 水素化植物油
• GMCC
• ハードファット
• 中鎖脂肪酸トリグリセリド
• レシチンとリン脂質
• オレイン酸ナトリウム
• カプリカプリル酸モノジグリセリド
• その他の賦形剤の種類
• 世界の医薬品用脂質ベース賦形剤市場：製品用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口製剤
• 非経口
• 局所適用
• 眼科用途
• 坐薬
• その他の製品用途
• 世界の医薬品用脂質ベース賦形剤市場：疾患別用途、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管疾患
• 神経疾患
• 腫瘍学
• 代謝障害
• ホルモン療法
• 感染症
• その他の疾患用途
• 世界の医薬品用脂質ベース賦形剤市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児用製品（0～18歳）
• 成人向け製品（19～64歳）
• 高齢者向け製品（65歳以上）
• 世界の医薬品用脂質ベース賦形剤市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬メーカー
• 契約開発製造組織
• その他のエンドユーザー
• 世界の医薬品用脂質ベース賦形剤市場、オイル、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 大豆油
• オリーブ油
• パーム油
• ひまわり油
• その他のオイル
• 世界の医薬品用脂質ベース賦形剤市場、水素化植物油、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 水素添加大豆油
• 水素化パーム油
• 水素化綿実油
• その他の水素化植物油
• 世界の医薬品用脂質ベース賦形剤市場、GMCC（C16/C18グリセリルモノまたはジエステル）、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• グリセリルモノステアレート
• グリセリルジステアレート
• グリセリルモノパルミテート
• その他のGMCC
• 世界の医薬品用脂質ベース賦形剤市場、ハードファット、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 水素化ヒマシ油
• 水素化パーム核油
• 水素化ココナッツオイル
• その他のハードファット
• 世界の医薬品用脂質ベース賦形剤市場、中鎖脂肪酸トリグリセリド（MCT）、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• カプリン酸トリグリセリド
• カプリル酸トリグリセリド
• カプリル酸-カプリン酸トリグリセリド
• その他のMCT
• 世界の医薬品用脂質ベース賦形剤市場、レシチンとリン脂質、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 大豆レシチン
• 卵レシチン
• ホスファチジルコリン
• ホスファチジルセリン
• その他のレシチンとリン脂質
• 世界の医薬品用脂質ベース賦形剤市場、オレイン酸ナトリウム、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品グレードのオレイン酸ナトリウム
• 食品グレードのオレイン酸ナトリウム
• 工業用オレイン酸ナトリウム
• 世界の医薬品用脂質ベース賦形剤市場、カプリル酸モノグリセリドまたはジグリセリド、実績と予測, 2019-2024, 2024-2029F, 2034F
• カプリン酸-カプリル酸モノグリセリド
• カプリン酸-カプリル酸ジグリセリド
• 世界の医薬品用脂質ベース賦形剤市場、その他の賦形剤、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ショ糖エステル
• 脂肪酸エステル
• PEG化脂質
• その他の脂質

第7章 地域別・国別分析

• 世界の医薬品用脂質ベース賦形剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品用脂質ベース賦形剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品用脂質ベース賦形剤市場：競合情勢
• 医薬品用脂質ベース賦形剤市場：企業プロファイル
  • Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • FUJIFILM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DuPont de Nemours Inc.
• Stepan Company
• Croda International
• Ashland Corporation
• NOF CORPORATION
• CordenPharma
• SEPPIC
• Nippon Fine Chemical Co. Ltd.
• Cayman Chemical
• ABITEC Corporation
• Creative Biolabs
• IOI Oleo GmbH
• Lipoid
• RuixiBiotechCo.Ltd
• Biosynth

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品用脂質ベース賦形剤市場2029：新たな機会を提供する国
• 医薬品用脂質ベース賦形剤市場2029：新たな機会を提供するセグメント
• 医薬品用脂質ベース賦形剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical lipid-based excipients are inactive substances derived from lipids that are used in drug formulations to aid in the delivery, stabilization, or enhancement of the absorption of the active pharmaceutical ingredient (API). These excipients are designed to improve the solubility, stability, and bioavailability of drugs, especially those that are poorly soluble in water.

The main types of pharmaceutical lipid-based excipients include oils, hydrogenated vegetable oils, glyceryl mono caprylate/caprate (GMCC), hard fats, medium-chain triglycerides, lecithin and phospholipids, sodium oleate, caprylic mono- and diglycerides, and others. Oils serve as non-aqueous carriers, enhancing the solubility of lipophilic drugs and improving their oral bioavailability. These excipients are used in various formulations such as oral, parenteral, topical, ophthalmic applications, suppositories, and more. They are employed in the treatment of a broad range of conditions, including cardiovascular diseases, neurological disorders, cancer, metabolic disorders, hormonal imbalances, and infectious diseases. Lipid-based excipients are formulated for all age groups pediatric (0-18 years), adult (19-64 years), and geriatric (65+ years). The key end users include pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and others.

The pharmaceutical lipid-based excipients treatment market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical lipid-based excipients treatment market statistics, including the pharmaceutical lipid-based excipients treatment industry global market size, regional shares, competitors with the pharmaceutical lipid-based excipients treatment market share, detailed pharmaceutical lipid-based excipients treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical lipid-based excipients treatment industry. This pharmaceutical lipid-based excipients treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical lipid-based excipients market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to several factors, including the increasing prevalence of poorly water-soluble drugs, higher demand for controlled and targeted drug release, a rise in pharmaceutical investments, the expansion of oral solid dosage forms, a greater focus on improving drug bioavailability, and the regulatory acceptance of lipid excipients in innovative formulations.

The pharmaceutical lipid-based excipients market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be attributed to the increasing demand for advanced drug delivery systems, the growing adoption of mRNA and gene therapies, an expanding pipeline of poorly water-soluble drugs, a stronger focus on personalized medicine, supportive regulatory frameworks, and strategic investments in biopharmaceutical manufacturing infrastructure. Key trends during this period include innovations in lipid nanoparticle delivery systems, wider adoption of mRNA and gene therapies, enhanced solubility solutions for poorly water-soluble drugs, the expansion of biocompatible and sustainable lipid sources, improved manufacturing scalability, and greater use in oral and injectable formulations.

The growth of gene therapy is expected to accelerate the expansion of the pharmaceutical lipid-based excipients market. Gene therapy involves modifying or manipulating a person's genes to treat or prevent disease. Its rise is largely driven by advancements in delivery systems that ensure safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients play a crucial role in enhancing gene therapy by enabling efficient delivery systems, providing stability, and ensuring the targeted transport of genetic material. These excipients improve therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, thereby increasing the effectiveness of modern treatments. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a U.S.-based non-profit organization, reported that the U.S. Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five in 2022. This growing trend in gene therapy is driving the demand for pharmaceutical lipid-based excipients.

Leading companies in the pharmaceutical lipid-based excipients market are making strategic investments to foster innovation, enhance formulation capabilities, and support drug delivery research. A notable example is Gattefosse SAS, a France-based chemical manufacturing company, which opened a state-of-the-art Technical Center of Excellence in Mumbai in November 2024. This facility aims to support India's growing pharmaceutical market, offering specialized laboratories and tailored support for excipient innovation, particularly in bioavailability, sustained release, and topical formulations. It will also strengthen Gattefosse's position in the Asia-Pacific region. The new facility is designed to encourage collaboration and foster innovation, providing a productive environment for research in pharmaceutical and personal care applications.

In June 2024, CordenPharma, a pharmaceutical company based in Switzerland, formed a partnership with Certest Biotec S.L., a Spain-based biotechnology company. The collaboration aims to integrate Certest's proprietary ionizable lipids into CordenPharma's lipid nanoparticle (LNP) formulation services. This partnership is set to enhance the development of RNA/DNA-based therapeutics by combining the expertise of both companies in lipid innovation, manufacturing, and regulatory compliance. Certest Biotec specializes in drug delivery through lipid nanoparticles (LNPs) and the synthesis of active pharmaceutical ingredients (APIs).

Major players in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth.

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical lipid-based excipients report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical lipid-based excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical lipid-based excipients market consists of sales of lipid excipients, specialty formulations, sterols, waxes, and glycolipids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Lipid-Based Excipients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical lipid-based excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical lipid-based excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical lipid-based excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Excipient Type: Oils; Hydrogenated Vegetable Oils; GMCC; Hard Fats; Medium Chain Triglycerides; Lecithin And Phospholipids; Sodium Oleate; Capri Caprylic Mono Diglyceride; Other Excipient Types
• 2) By Product Applications: Oral Formulations; Parenteral; Topical Applications; Ophthalmic Applications; Suppositories; Other Product Applications
• 3) By Disease Application: Cardiovascular Diseases; Neurological Disorders; Oncology; Metabolic Disorders; Hormonal Therapies; Infectious Diseases; Other Disease Applications
• 4) By Age Group: Pediatric Products (0-18 years); Adult Products (19-64 years); Geriatric Products (65+ years)
• 5) By End-Use: Pharmaceutical Manufacturers; Contract Development And Manufacturing Organizations; Other End Users
• Subsegments:
• 1) By Oils: Soybean Oil; Olive Oil; Palm Oil; Sunflower Oil; Other Oils
• 2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil; Hydrogenated Palm Oil; Hydrogenated Cottonseed Oil; Other Hydrogenated Vegetable Oils
• 3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate; Glyceryl Distearate; Glyceryl Monopalmitate; Other GMCC
• 4) By Hard Fats: Hydrogenated Castor Oil; Hydrogenated Palm Kernel Oil; Hydrogenated Coconut Oil; Other Hard Fats
• 5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides; Caprylic Triglycerides; Caprylic-Capric Triglycerides; Other MCTs
• 6) By Lecithin and Phospholipids: Soy Lecithin; Egg Lecithin; Phosphatidylcholine; Phosphatidylserine; Other Lecithin and Phospholipids
• 7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate; Food Grade Sodium Oleate; Industrial Grade Sodium Oleate
• 8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides; Capric-Caprylic Diglycerides
• 9) By Other Excipient Types: Sucrose Esters; Fatty Acid Esters; PEGylated Lipids; Other Miscellaneous Lipids
• Companies Mentioned: Cargill Incorporated; BASF SE; Merck KGaA; FUJIFILM Corporation; Evonik Industries AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Lipid-Based Excipients Market Characteristics

3. Pharmaceutical Lipid-Based Excipients Market Trends And Strategies

4. Pharmaceutical Lipid-Based Excipients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Lipid-Based Excipients Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Lipid-Based Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Lipid-Based Excipients Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Lipid-Based Excipients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Lipid-Based Excipients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Lipid-Based Excipients Total Addressable Market (TAM)

6. Pharmaceutical Lipid-Based Excipients Market Segmentation

• 6.1. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oils
• Hydrogenated Vegetable Oils
• GMCC
• Hard Fats
• Medium Chain Triglycerides
• Lecithin And Phospholipids
• Sodium Oleate
• Capri Caprylic Mono Diglyceride
• Other Excipient Types
• 6.2. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Formulations
• Parenteral
• Topical Applications
• Ophthalmic Applications
• Suppositories
• Other Product Applications
• 6.3. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Neurological Disorders
• Oncology
• Metabolic Disorders
• Hormonal Therapies
• Infectious Diseases
• Other Disease Applications
• 6.4. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Products (0-18 years)
• Adult Products (19-64 years)
• Geriatric Products (65+ years)
• 6.5. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Manufacturers
• Contract Development And Manufacturing Organizations
• Other End Users
• 6.6. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Oils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soybean Oil
• Olive Oil
• Palm Oil
• Sunflower Oil
• Other Oils
• 6.7. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Hydrogenated Vegetable Oils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogenated Soybean Oil
• Hydrogenated Palm Oil
• Hydrogenated Cottonseed Oil
• Other Hydrogenated Vegetable Oils
• 6.8. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of GMCC (Glyceryl Mono Or Diesters Of C16/C18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glyceryl Monostearate
• Glyceryl Distearate
• Glyceryl Monopalmitate
• Other GMCC
• 6.9. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Hard Fats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogenated Castor Oil
• Hydrogenated Palm Kernel Oil
• Hydrogenated Coconut Oil
• Other Hard Fats
• 6.10. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Medium Chain Triglycerides (MCTs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capric Triglycerides
• Caprylic Triglycerides
• Caprylic-Capric Triglycerides
• Other MCTs
• 6.11. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Lecithin And Phospholipids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soy Lecithin
• Egg Lecithin
• Phosphatidylcholine
• Phosphatidylserine
• Other Lecithin And Phospholipids
• 6.12. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Sodium Oleate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Grade Sodium Oleate
• Food Grade Sodium Oleate
• Industrial Grade Sodium Oleate
• 6.13. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Capri-Caprylic Mono Or Diglycerides, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capric-Caprylic Monoglycerides
• Capric-Caprylic Diglycerides
• 6.14. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Other Excipient Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sucrose Esters
• Fatty Acid Esters
• PEGylated Lipids
• Other Miscellaneous Lipids

7. Pharmaceutical Lipid-Based Excipients Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Lipid-Based Excipients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Lipid-Based Excipients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market

• 8.1. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Lipid-Based Excipients Market

• 9.1. China Pharmaceutical Lipid-Based Excipients Market Overview
• 9.2. China Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Lipid-Based Excipients Market

• 10.1. India Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Lipid-Based Excipients Market

• 11.1. Japan Pharmaceutical Lipid-Based Excipients Market Overview
• 11.2. Japan Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Lipid-Based Excipients Market

• 12.1. Australia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Lipid-Based Excipients Market

• 13.1. Indonesia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Lipid-Based Excipients Market

• 14.1. South Korea Pharmaceutical Lipid-Based Excipients Market Overview
• 14.2. South Korea Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Lipid-Based Excipients Market

• 15.1. Western Europe Pharmaceutical Lipid-Based Excipients Market Overview
• 15.2. Western Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Lipid-Based Excipients Market

• 16.1. UK Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Lipid-Based Excipients Market

• 17.1. Germany Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Lipid-Based Excipients Market

• 18.1. France Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Lipid-Based Excipients Market

• 19.1. Italy Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Lipid-Based Excipients Market

• 20.1. Spain Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Lipid-Based Excipients Market

• 21.1. Eastern Europe Pharmaceutical Lipid-Based Excipients Market Overview
• 21.2. Eastern Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Lipid-Based Excipients Market

• 22.1. Russia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Lipid-Based Excipients Market

• 23.1. North America Pharmaceutical Lipid-Based Excipients Market Overview
• 23.2. North America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Lipid-Based Excipients Market

• 24.1. USA Pharmaceutical Lipid-Based Excipients Market Overview
• 24.2. USA Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Lipid-Based Excipients Market

• 25.1. Canada Pharmaceutical Lipid-Based Excipients Market Overview
• 25.2. Canada Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Lipid-Based Excipients Market

• 26.1. South America Pharmaceutical Lipid-Based Excipients Market Overview
• 26.2. South America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Lipid-Based Excipients Market

• 27.1. Brazil Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Lipid-Based Excipients Market

• 28.1. Middle East Pharmaceutical Lipid-Based Excipients Market Overview
• 28.2. Middle East Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Lipid-Based Excipients Market

• 29.1. Africa Pharmaceutical Lipid-Based Excipients Market Overview
• 29.2. Africa Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Lipid-Based Excipients Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Lipid-Based Excipients Market Competitive Landscape
• 30.2. Pharmaceutical Lipid-Based Excipients Market Company Profiles
  • 30.2.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. FUJIFILM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Lipid-Based Excipients Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Stepan Company
• 31.3. Croda International
• 31.4. Ashland Corporation
• 31.5. NOF CORPORATION
• 31.6. CordenPharma
• 31.7. SEPPIC
• 31.8. Nippon Fine Chemical Co. Ltd.
• 31.9. Cayman Chemical
• 31.10. ABITEC Corporation
• 31.11. Creative Biolabs
• 31.12. IOI Oleo GmbH
• 31.13. Lipoid
• 31.14. RuixiBiotechCo.Ltd
• 31.15. Biosynth

32. Global Pharmaceutical Lipid-Based Excipients Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Lipid-Based Excipients Market

34. Recent Developments In The Pharmaceutical Lipid-Based Excipients Market

35. Pharmaceutical Lipid-Based Excipients Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Lipid-Based Excipients Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Lipid-Based Excipients Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Lipid-Based Excipients Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer